Laparoscopic myotomy or pneumatic dilatation for achalasia treatment?

Kiudelis, Mindaugas; Mickevičius, Antanas; Maleckas, Almantas; Endzinas, Žilvinas; Kiudelis, Gediminas; Jonaitis, Laimonas; Kupčinskas, Limas

doi:10.2478/s11536-011-0072-7

Cited by 1 publication

(1 citation statement)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…3 Therapeutic options for achalasia include endoscopic pneumatic balloon dilation (PBD), 1 intrasphincteric botulinum toxin injections, 4 ethanolamine oleate injections, 5,6 peroral endoscopic myotomy, and surgical treatments such as minimally invasive laparoscopic or thoracoscopic cardiomyotomy. [7][8][9] PBD has been a well-established treatment for many years, and is a relatively inexpensive outpatient procedure 10 associated with high success rates ranging from 70% to 90%. 11 Esophageal perforation is the most serious complication that occurs in about 2-4% of cases.…”

Section: Introductionmentioning

confidence: 99%

Safety and Efficacy of Graded Gradual Pneumatic Balloon Dilation in Idiopathic Achalasia Patients: A 24-Year Single-Center Experience

et al. 2021

View full text Add to dashboard Cite

Background: Pneumatic balloon dilation (PBD) is a first line treatment for idiopathic achalasia. Here we report the safety and efficacy of graded gradual PBD on short and long-term follow-up. Methods: We evaluated 1370 idiopathic achalasia patients over a period of 24 years (1994-2018), prospectively. 216 patients did not undergo PBD due to comorbid diseases. Ultimately, 1092 achalasia patients were enrolled. All patients underwent graded gradual PBD, with repeat dilation if symptoms relapsed. Response to treatment was evaluated by Vantrappen scoring system. Results: Of 1092 achalasia patients, 937 patients were treated by PBD and 155 patients were treated by combined therapy (PBD 1 month after Botulinum toxin injection). In short-term follow-up, 728 of 1092 patients underwent one PBD and 77.3% of them had excellent or good response (responders), 163 patients (58.6%) who underwent two PBDs were responders, and 44 (51.2%) patients who underwent three PBDs were responders. Overall, 2193 balloon dilations were performed on 1092 patients (mean 2 PBDs/patient). Of 786 patients with long-term follow-up, 259 patients had excellent or good response with one PBD. The responders with two, three, and four or more dilations were 149, 67, and 67, respectively. The overall response rate was 69%. No any serious complications were noted by using the graded gradual method. Conclusion: Our results show that graded gradual PBD is a safe and effective method for treatment of achalasia patients, and achieves sufficient short and long-term symptomatic remission with high cumulative success rate.

show abstract